Similar to recent studies [9, 10, 13] the risk for patients with p.A143T in our study with only slightly reduced GLA activities (males) and/or normal lyso-Gb3 levels (males and females) for renal and cardiac end organ damage was reduced in comparison to other FD patients with classical missense mutations. This evidence concerns the gene GLA and Fabry disease.